Canine Biologics

Millions of dogs with cancer need this first-of-its-kind nutrition system

https://wefunder.com/canine.biologics

Total raised on Wefunder: 57571

Total investors: 26

Quick facts

  • 8 consecutive months of positive revenue growth since entering the market. (Nov - May)
  • Market Potential: 500,000 dogs (US and Canada) diagnosed with cancer each month
  • Experienced team includes PhD veterinarians with advanced expertise in nutrition and cancer care
  • We believe there are no other companies offering complete products (food + supplements) for dogs with cancer
  • Expanded product roadmap includes formulated treats, liquid diet for dogs requiring tube feeding

Team profiles

Featured investor profiles

Canine Biologics

Millions of dogs with cancer need this first-of-its-kind nutrition system

Funded badge
Last Funded August 2021

$57,571

raised from 26 investors
Pitch Video
Investor Panel

Investor Panel

Tony and Daniel interviewed Canine Biologics on May 20, 2021. Play Video
Tony Wilkins
Tony Wilkins
Private investor at Standing Oaks Venture Partners. Started investing in 1991. I invest in coachable people who I admire, respect and trust.
Daniel Edwards
Daniel Edwards
Daniel is a startup CEO, angel investor, advisor and board member spanning from London to Silicon Valley.
Strengths
says, "Knowing that you furry family member is being comforted as best as possible during a difficult time is priceless. The care, love and science infused into Canine Biologics will help pet parents know that they are doing the best they possibly can for their pet during a difficult time."
says, "Jeff and the Canine Biologics team have built a great product that already has users raving about the product. It is early days, but the reviews from the first users are great. Jeff even told me about a story where a veterinary forgot his lunch so he ate the Canine Biologics product and liked it, just a testament of quality and taste. Excited to see this great product with a good purpose scale."
Advice
says, "More stories of other families for whom Canine Biologics has been helpful will help both the raise as well as the community of pet parents."
says, "Jeff told me that they've had difficulty with direct to consumer, but seen success with working with veterinarians. I would suggest to double down on working with the veterinarians as that is an important partner in selling this product. You can always focus on direct to consumer later."

What Investors Say

LEAD INVESTOR
Invested $5,000 this round
As the Lead Investor I am backing Canine Biologics because I strongly believe in the power of nutrition and its effect on health. I have personally seen the difference that great, human-grade food has made with my dog. Canine Biologics goes several steps further with their approach to specialized nutrition for dogs battling cancer. Last year, Jeff and his team brought to market a product unlike any other to support dogs with this devastating disease. While many facets of the treatment realm continue to evolve, I am excited to be a part of helping pet parents and their furry companions today.
What People Say